Gland Pharma Ltd intimated SEBI-compliant schedule of analyst/institutional investor meetings from March 18-20, 2026.
Disclosed Non-Deal Roadshow with Elara (USA) on March 19 under one-on-one meeting format through regulatory filing.
Company Secretary confirmed no unpublished price sensitive information will be shared during investor interactions.